Life Sciences

At JPM24, the tech giant announced plans to expand individuals' access to digital health benefits, tapping chronic care management company Omada Health as a partner.

The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.

Sehat Kahani is now exploring predictive AI in telehealth.

Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.  

At the HIMSS AI Conference in San Diego, panelists discussed the steps needed to strategically incorporate AI into the healthcare setting.

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.